Alzheimer’s Disease/Dementia News

The American Psychiatric Association on Wednesday announced the launch of PsychPRO 2.0, a mental health registry that offers psychiatrists enhanced options to engage with patients, track outcomes and streamline data for quality reporting.

CMS announced that Medicare is limiting coverage of the controversial Alzheimer’s disease drug Aduhelm to participants who are enrolled in FDA- or NIH-approved clinical trials.

Cyclica and Arctoris have expanded their partnership to progress drug discovery programs for novel neurodegenerative targets, focusing on Alzheimer’s disease, according to a press release.

Moderate to vigorous physical activity was associated with decreased risk of disabling dementia in men, according to a study published in JAMA Network Open.

Younger or older age at menarche, younger age at first birth, and hysterectomy — all of which affect lifetime exposure to endogenous estrogen — were associated with a higher risk for dementia in women, researchers found.

SEATTLE — Self-administered home use of gamma sensory stimulation reduced brain atrophy safely in people with Alzheimer’s disease, a presenter said at the 2022 American Academy of Neurology annual meeting.

Quanterix Corp. announced it has partnered with the Alzheimer’s Drug Discovery Foundation to accelerate the development of a multi-analyte plasma test for early detection of Alzheimer’s disease.

Large amounts of tau proteins in the brain affected memory function only when amyloid protein burden was also high in those with Alzheimer’s disease, data suggests in a study published in Brain.

Older patients taking psychotropic medication were about three times more likely to develop dementia following a SARS-CoV-2 infection, researchers reported in Frontiers in Medicine.

The American Heart Association/American Stroke Association have published a joint recommendation statement for the use of endovascular therapy and thrombolysis following stroke in patients with premorbid dementia or disability.